We serve Chemical Name:4-oxopiperidine-3-carbonitrile CAS:19166-75-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-oxopiperidine-3-carbonitrile
CAS.NO:19166-75-7
Synonyms:4-oxopiperidine-3-carbonitrile;3-Cyano-4-piperidon;3-Piperidinecarbonitrile, 4-oxo-;4-Oxo-piperidin-3-carbonitril;3-Cyano-4-Piperidone;4-Oxo-3-piperidinecarbonitrile;4-OXO-NIPECOTONITRILE;4-oxo-piperidine-3-carbonitrile;3-Cyano-4-Piperidione
Molecular Formula:C6H8N2O
Molecular Weight:124.141
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:300.8±37.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.491
PSA:52.89000
Exact Mass:124.063660
LogP:-1.20
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-oxopiperidine-3-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Cyano-4-Piperidione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-oxo-piperidine-3-carbonitrile Use and application,3-Cyano-4-Piperidone technical grade,usp/ep/jp grade.
Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. 4-oxopiperidine-3-carbonitrile manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 4-oxopiperidine-3-carbonitrile supplier There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 4-oxopiperidine-3-carbonitrile vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 4-oxopiperidine-3-carbonitrile factory The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.
